BXRX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 Feb 2024 @ 15:53):

Stats
Today's Volume	310 872
Average Volume	424 847
Market Cap	950 330
EPS	$0 ( 2024-05-10 )
Next earnings date	( $0 ) 2024-08-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.000232
ATR14	$0.00100 (4.59%)

Insider Trading

Date	Person	Action	Amount	type
2023-10-09	Mcandrew Natalie	Buy	0
2023-07-03	Kim Yong Chan	Sell	0	Common Stock
2023-07-03	Kim Yong Chan	Sell	4 520 066	Series X Preferred Stock
2022-12-15	Henwood Geraldine	Buy	1 200	Common Stock
2022-06-15	Ashton William	Buy	39 473	Common Stock

INSIDER POWER
-98.81
Last 86 transactions
Buy: 13 000 393 \| Sell: 13 896 192

Baudax Bio Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Baudax Bio Inc Financials

Annual	2022
Revenue:	$1.27M
Gross Profit:	$-5.74M (-452.32 %)
EPS:	$-177.30

FY	2022
Revenue:	$1.27M
Gross Profit:	$-5.74M (-452.32 %)
EPS:	$-177.30

FY	2021
Revenue:	$1.08M
Gross Profit:	$-1.37M (-126.39 %)
EPS:	$-2 287 839

FY	2020
Revenue:	$493 000
Gross Profit:	$-1.24M (-251.32 %)
EPS:	$-8 806 947

Financial Reports:

No articles found.

Baudax Bio Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Baudax Bio Inc

Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMBA, which is in phase I clinical trial; BX3000, an NMBA reversal agent; and Dex-IN, a proprietary intranasal formulation of dexmedetomidine. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.